{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:49:05Z","timestamp":1787312945540,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jpba.2024.116532","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:16:43Z","timestamp":1729127803000},"page":"116532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Separation of tolperisone and its degradation products by a dual cyclodextrin capillary electrophoresis system to study their potential role in allergic events"],"prefix":"10.1016","volume":"252","author":[{"given":"P\u00e9ter P.","family":"Lakatos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Ign\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Csern\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Boldizs\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Sz\u00f6k\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"T\u00e1bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116532_bib1","unstructured":"Questions and answers on the review of tolperisone-containing medicines, European Medicines Agency, EMA\/673365\/2012 rev.1, 2013."},{"key":"10.1016\/j.jpba.2024.116532_bib2","article-title":"Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis","volume":"380","author":"Wewege","year":"2023","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jpba.2024.116532_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12272-022-01422-1","article-title":"Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone","volume":"46","author":"Cho","year":"2023","journal-title":"Arch. Pharm. Res."},{"issue":"8","key":"10.1016\/j.jpba.2024.116532_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ph16081115","article-title":"Pregabalin-tolperisone combination to treat neuropathic pain: improved analgesia and reduced side effects in rats","volume":"16","author":"Essmat","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"17","key":"10.1016\/j.jpba.2024.116532_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179564","article-title":"The acute antiallodynic effect of tolperisone in rat neuropathic pain and evaluation of its mechanism of action","volume":"23","author":"Lakatos","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.jpba.2024.116532_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030224","article-title":"Risk factors of anaphylaxis in Korea: identifying drug-induced anaphylaxis culprits using big data","volume":"101","author":"Ahn","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.jpba.2024.116532_bib7","first-page":"369","article-title":"Anaphylactic reactions to tolperisone (mydocalm)","volume":"133","author":"Ribi","year":"2003","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.jpba.2024.116532_bib8","series-title":"Allergic Contact Dermatitis: The Molecular Basis","author":"Lepoittevin","year":"1998"},{"issue":"1","key":"10.1016\/j.jpba.2024.116532_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3797\/scipharm.1209-17","article-title":"Development and validation of a precise, single HPLC method for the determination of tolperisone impurities in API and pharmaceutical dosage forms","volume":"81","author":"Raju","year":"2013","journal-title":"Sci. Pharm."},{"issue":"5","key":"10.1016\/j.jpba.2024.116532_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/dmd.31.5.631","article-title":"Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes","volume":"31","author":"Dalmadi","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2024.116532_bib11","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1021\/ac970418o","article-title":"A family of single-isomer chiral resolving agents for capillary electrophoresis. 2. Hepta-6-sulfato-beta-cyclodextrin","volume":"69","author":"Vincent","year":"1997","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116532_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0021-9673(99)00235-6","article-title":"Sample concentration by sample stacking and sweeping using a microemulsion and a single-isomer sulfated beta-cyclodextrin as pseudostationary phases in electrokinetic chromatography","volume":"838","author":"Quirino","year":"1999","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116532_bib13","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/(SICI)1522-2683(19991101)20:17<3432::AID-ELPS3432>3.0.CO;2-8","article-title":"Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis","volume":"20","author":"Desiderio","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2024.116532_bib14","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/(SICI)1522-2683(19990901)20:13<2691::AID-ELPS2691>3.0.CO;2-S","article-title":"Designed combination of chiral selectors for adjustment of enantioseparation selectivity in capillary electrophoresis","volume":"20","author":"Fillet","year":"1999","journal-title":"Electrophoresis"},{"issue":"15","key":"10.1016\/j.jpba.2024.116532_bib15","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/elps.200305468","article-title":"Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine","volume":"24","author":"Tabi","year":"2003","journal-title":"Electrophoresis"},{"issue":"8","key":"10.1016\/j.jpba.2024.116532_bib16","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00216-012-6384-x","article-title":"Chiral separation and determination of excitatory amino acids in brain samples by CE-LIF using dual cyclodextrin system","volume":"404","author":"Wagner","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"issue":"10","key":"10.1016\/j.jpba.2024.116532_bib17","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jssc.202100991","article-title":"Sensitive and selective LC-MS\/MS for the determination of tolperisone and etodolac in human plasma and application to a pharmacokinetic study","volume":"45","author":"Helmy","year":"2022","journal-title":"J. Sep. Sci."},{"issue":"6","key":"10.1016\/j.jpba.2024.116532_bib18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.5740\/jaoacint.13-295","article-title":"Rapid simultaneous determination of eperisone, tolperisone, and tizanidine in human serum by using a MonoSpin(R) C18 extraction column and liquid chromatography\/tandem mass spectrometry","volume":"97","author":"Miura","year":"2014","journal-title":"J. AOAC Int."},{"issue":"10","key":"10.1016\/j.jpba.2024.116532_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/chir.22187","article-title":"Enantioselective separation and simultaneous determination of tolperisone and eperisone in rat plasma by LC-MS\/MS","volume":"25","author":"Nageswara Rao","year":"2013","journal-title":"Chirality"},{"key":"10.1016\/j.jpba.2024.116532_bib20","unstructured":"ICoH International Conference on Harmonization, Validation of Analytical Procedures: Text and Methodology Q2(R1), 2005."},{"key":"10.1016\/j.jpba.2024.116532_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0021-9673(01)01371-1","article-title":"Prediction of selectivity for enantiomeric separations of uncharged compounds by capillary electrophoresis involving dual cyclodextrin systems","volume":"948","author":"Abushoffa","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116532_bib22","unstructured":"Impurities in New Drug Products, European Medicines Agency, ICH Topic Q 3 B (R2). (Accessed 2024)."},{"issue":"2","key":"10.1016\/j.jpba.2024.116532_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfm064","article-title":"Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach","volume":"97","author":"Gerberick","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.jpba.2024.116532_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000068288","article-title":"Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide-hapten adducts","volume":"16","author":"Ahlfors","year":"2003","journal-title":"Ski. Pharm. Appl. Ski. Physiol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524005740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524005740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T14:27:59Z","timestamp":1730644079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524005740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S0731708524005740"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116532","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Separation of tolperisone and its degradation products by a dual cyclodextrin capillary electrophoresis system to study their potential role in allergic events","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116532"}}